Bluejay Diagnostics, Inc. ( BJDX) - Key Metrics
BJDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.12 | -$0.72 | -$0.79 |
| 2026Q1 | $0 | -$4.27 | -$3.54 | -$3.58 |
| 2025Q4 | $0 | -$3.18 | -$3.24 | -$3.63 |
| 2025Q3 | $0 | -$4.06 | -$3.45 | -$3.45 |
| 2025Q2 | $0 | -$5.64 | -$5.92 | -$5.92 |
BJDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.27 |
| 2026Q1 | 0% | -0.11 |
| 2025Q4 | 0% | -0.28 |
| 2025Q3 | 0% | -0.38 |
| 2025Q2 | 0% | -0.30 |
BJDX
Price: $0.90
52 week price:
Earnings Per Share: -2.24 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 114300
Market Capitalization: 861296